 prognost factor aggress malign lymphoma descript valid prognost index patient intens therapi group d'etud de lymphom agressif object studi prognost factor respons treatment freedom-from-relaps ffr surviv overal surviv aggress malign lymphoma patient doxorubicin cyclophosphamid vindesin bleomycin methylprednisolon methotrex leucovorin ifosfamid asparaginas cytarabin regimen prognost index factor multivari analys prognost index set patient complet respons CR patient median follow-up month median ffr surviv median overal surviv low serum albumin level high tumor mass weight loss bone marrow involv equal extranod site lactic dehydrogenas ldh level low respons rate advanc stage ldh level nonlarge-cel histolog subtyp mix lymphoblast small non-cleav high relaps rate short ffr surviv ldh level low serum albumin level tumor mass cm equal extranod site advanc stage age year short overal surviv paramet ldh level stage number extranod site tumor mass prognost index index patient subgroup good intermedi poor prognosi CR rate relaps rate ffr surviv surviv prognost index test set patient patient protocol nebraska lymphoma studi group index patient ffr surviv surviv patient aggress lymphoma simpl prognost index patient intens treatment autolog bone marrow transplant first complet remiss standard regimen